New York State Biodefense Commercialization Fund

There are presently no open calls for submissions.

New York State Biodefense Commercialization Fund


SHORT PROPOSAL DEADLINE EXTENDED TO: MONDAY, OCTOBER 4TH AT 5:00PM EST

Following is an overview of the Biodefense Commercialization Fund program and requirements. More details can be found by reading the Biodefense Commercialization Fund Guidelines. http://www.esd.ny.gov/biodefensefund  

The Program Overview:

The $40 million Biodefense Commercialization Fund is intended to encourage and accelerate focuses on encouraging and accelerating the development and commercialization of solutions for serious infectious disease threats, including COVID-19 and its variants, while fostering the creation of new life science businesses and supporting industry growth.

Areas of Interest:

Applications for all therapeutic, diagnostic and digital epidemiology projects with a translational/commercialization trajectory are encouraged.  Special consideration may be given to small molecule therapeutics and novel platform diagnostics targeting COVID, its variants, or other infectious disease threats.

Eligibility:

  • Startup companies based in New York State that have recently raised or are in the process of raising Seed, Series A, or Series B funding, and startup companies from outside of New York State that meet the above qualifications and intend to relocate to New York State
  • New York-based academic institutions developing advanced IP and translational innovations that are on the cusp of moving into a commercial development phase

Funding

  • Startup Companies are eligible to receive between $1 Million - $4 Million in award funding
  • Academic Institutions are eligible to receive between $250K - $500K in award funding

Application Review Criteria

Applications will be reviewed by an expert review panel based on the following criteria:

  • Innovation & Value Proposition
  • Intellectual Property
  • Team Experience & Capabilities
  • Approach & Feasibility of technology
  • Relevance and Applicability to Future Infectious Disease Threats


Questions?

Please e-mail BiodefenseFund@esd.ny.gov

New York State Biodefense Commercialization Fund